Oxygen heterogeneity in solid tumours is recognised as a limiting factor for therapeutic efficacy. Vessel normalisation strategies, aimed at rescuing abnormal tumour vascular phenotypes and alleviating hypoxia, have the potential to improve tumour responses to treatments such as radiotherapy and chemotherapy. However, understanding how pathological blood vessel networks and oxygen transport are related remains limited. In this paper, we propose a novel source of oxygen heterogeneity in tumour tissue associated with the abnormal transport of red blood cells. We calculate average vessel lengthsL and diametersd from tumour allografts of three cancer cell lines and observe a substantial reduction in the ratio λ =L/d compared to physiological conditions. Mathematical modelling reveals that small values of the ratio λ (i.e. λ < 6) can bias haematocrit distribution in tumour vascular networks and drive heterogeneous oxygenation of tumour tissue. Finally, we show an increase in the value of λ in tumour vascular networks following treatment with the anti-angiogenic cancer agent DC101. Based on our findings, we propose a mechanism for oxygen normalisation associated with an increase in λ following treatment with anti-angiogenic drugs.